Epzicom

This page contains recent news articles, when available, and an overview of Epzicom but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

High Viral Load Patients Equally Fine on Epzicom or Truvada  -  ‎Aug 7, 2009‎
These results counter a previously reported study that suggested abacavir—notably its Epzicom co-formulation with lamivudine—is less likely to keep viral AIDSmeds.com HIV/AIDS Treatment News

Gradual Efavirenz Dosing Shows Promise  -  ‎Jul 7, 2009‎
The 114 patients enrolled received efavirenz plus either Truvada (tenofovir and emtricitabine), Epzicom (abacavir and lamivudine) or a combination of two AIDSmeds.com HIV/AIDS Treatment News

Comparative Medicine Could Sink Your Stocks  -  ‎Jun 20, 2009‎
For instance, last Epzicom compound. The results seem to be helping Gilead capture new patients. Last quarter, sales of Truvada were up 23% with a slight The Money Times

Gilead Initiates Phase II Clinical Trial Of Integrase-Based ...  -  20 Apr 2009
Epivir® or Epivir-HBV® (lamivudine), Epzicom™ (abacavir sulfate/lamivudine) or Trizivir® (abacavir sulfate/lamivudine/zidovudine). Medical News Today (press release)

�?��?�벌 화�?��?/GSK, �?�?�즈사업�? �? 잡았다  -  20 Apr 2009
...화�?��?�?� 신제품 파�?�프�?��?�으로는 Epzicom�?� 특허 만료로 Selzentry가 대체�?� 예정�?�며 GSK�?� �?매력�? �?��?� 볼 것으로 예측하고 있다. �? 회사�?� 합작 회사는 런�?��? 메디포뉴스

Gilead initiiert Phase II klinischer Studie zur HIV-Behandlung ...  -  20 Apr 2009
Dazu gehören Combivir ® (Lamivudin/Zidovudin), Epivir ® und Epivir-HBV ® (Lamivudin), Epzicom™ (Abacavirsulfat/Lamivudin) sowie Trizivir Business Wire (press release)

Glaxo, Pfizer to Merge HIV-Drug Units in Challenge to Gilead  -  ‎Apr 16, 2009‎
London-based Glaxo, which sells Combivir and Epzicom for HIV, made history in 1987 when its predecessor company, Burroughs Wellcome, developed a drug that Bloomberg

2 Virus Killers Are Better Than 1  -  ‎Apr 16, 2009‎
...of Health clinical trial last year that concluded that Gilead Sciences' (Nasdaq: GILD) Truvada HIV combo drug worked better than Glaxo's Epzicom. Motley Fool

HIV/AIDS Update - Tentative approval of abacavir sulfate and ...  -  ‎Mar 31, 2009‎
This tentative approval is for a generic version of Epzicom tablets, a Nucleoside Reverse Transcriptase Inhibitor (NRTI), made by GlaxoSmithKline. PharmaLive.com (press release)

GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create ...  -  ‎Apr 16, 2009‎
Epivir/3TC NRTI GSK 2248761 NNRTI II (IDX899) Epzicom/Kivexa NRTI PF-232798 CCR5 antagonist II Lexiva/Telzir Protease inhibitor PF-3716539 PK enhancer I PR Newswire (press release)

Glaxo, Pfizer Join to Create New Drug Company  -  ‎Apr 17, 2009‎
...behind leader Gilead Sciences Inc. and will have several market-leading therapies, including Combivir, Epzicom/Kivexa and Pfizer's Selzentry/Celsentri. TopNews United States

Glaxo and Pfizer pool AIDS drugs in new company  -  ‎Apr 16, 2009‎
It will include 11 already marketed products -- including Glaxo's top-sellers, Combivir and Epzicom -- that together generated sales of 1.6 billion pounds Interactive Investor

Glaxo and Pfizer create new HIV drug company  -  ‎Apr 16, 2009‎
The new company will have several market-leading therapies, including Combivir, Epzicom/Kivexa and Pfizer's Selzentry/Celsentri. The combined portfolio had Boston Herald

Las farmacéuticas Glaxo y Pfizer unen sus negocios de fármacos ...  -  ‎Apr 17, 2009‎
...la primera británica y la segunda estadounidense, se fusionarán para comercializar once fármacos que producen actualmente, como Combivir y Epzicom, La Nueva España

Glaxo e Pfizer formam empresa para tratamento da AIDS  -  ‎Apr 16, 2009‎
A nova companhia terá 11 produtos comercializados --incluindo os mais vendidos da Glaxo, Combivir e Epzicom--, que juntos geraram vendas de 1,6 bilhão de Abril

葛兰素�?�?�克和辉瑞�?�手�?立艾滋病�?�物公�?�  -  ‎Apr 17, 2009‎
...新�?�网纽约４月１６日电英国葛兰素�?�?�克和美国辉瑞两大著�??制�?��?业１６日宣布，将�?�作�?立一家新公�?�，专门研制和销售抵御艾滋病的�?�物，期望以较少投资在抗击新华网

GSK-화�?��?, HIV치료제 개발 공�?�벤처 설립  -  ‎Apr 16, 2009‎
...새로운 벤처회사는 최대 매출품목�?� GSK�?� ‘컴비비어(Combivir)'와 '�?프지콤(Epzicom)'�?� �?�함해 시중�? 유통�?�는 11종�?� HIV제품�?� 보유하게 �??으며 6개�?� 실험약�?� 데일리팜

辉瑞与GSK兵团作战,�?��?�抗艾市场两�?份�?  -  ‎Apr 19, 2009‎
...新公�?�将拥有�?�方已�?�市的11�?�?�物，包括葛兰素�?�克最畅销的�?�汰�?和Epzicom.此外还有6�?研制中的新�?�，其中4�?处于研�?�的第二阶段。新公�?��??将在年底开始�?作时确定，凤凰网

Gilead initie un essai clinique de Phase II avec un régime ...  -  ‎Apr 19, 2009‎
...l'Epivir ® ou l' Epivir-HBV ® (lamivudine), l'Epzicom™ (abacavir sulfate/lamivudine) ou le Trizivir ® (abacavir sulfate/lamivudine/zidovudine). Euroinvestor

GSK与Idenix�?�作开�?�新型HIV治疗�?�物�?景难测  -  ‎Mar 17, 2009‎
...�?�物安全�?�机无疑削弱了三�?�用�?�的市场开�?�潜力，Epzicom上市�?�全�?�销售�?增长幅度一直�?甚�?�想，2005年仅为2.2亿美元，2006年拉�?�至4.5亿美元，2007年也仅为6.5亿美元搜狐

Worth Every Penny  -  Jan 28, 2009
Gilead is guiding for flat SG&A expenses as revenues to increase 16% to 18% next year as it benefits from GlaxoSmithKline's (NYSE: GSK) Epzicom downgrade to Motley Fool

AIDS Drugs Boost Risk of Heart Attacks  -  Jan 12, 2009
In January, a federal panel officially recommended that a combination of abacavir and the antiviral drug 3TC (brand name Epzicom) be the "preferred choice" Natural News.com,

The New America  -  Dec 16, 2008
But rival drug Epzicom from GlaxoSmithKline (GSK) was bumped off the preferred list to an "alternative" status. "So Gilead is benefiting from both a Investor's Business Daily (subscription)

Gilead Earnings Sound Death Knell (Again) for Large Sales Forces  -  Oct 18, 2008
That growth came after its HIV drug, Truvada, beat GlaxoSmithKline’s Epzicom in a head-to-head trial, making it the first-line defense against AIDS. BNET,

Presence of Newcomers Forcing Changes in Blockbuster HIV Drug Market  -  Sep 24, 2008
Among its eight marketed products is FDC Epzicom (also called Kivexa) – a Truvada competitor – but several independent studies have highlighted that Epzicom Network Médica,

HIV drug market will hit $15.1 billion by 2017, but competition ...  -  Sep 30, 2008
The company had to face further problems this year when several independent studies highlighted that GSK's main hope Epzicom, an FDC competing with Gilead's PR-Inside.com (Pressemitteilung),

Gilead Sciences Killed It  -  Oct 17, 2008
Institutes of Health clinical trial earlier this year that pitted Gilead’s Truvada HIV combo drug against GlaxoSmithKline's (NYSE: GSK) Epzicom. Motley Fool

HIV drug market to grow, but not for everyone  -  Sep 25, 2008
A further setback for GSK arrived when several independent studies found its Epzicom FDC – a Truvada competitor – is both less efficacious in certain Medical Marketing and Media,

HIV治療薬�?�市場シェア�?�得�?�戦�?�激化  -  Oct 7, 2008
GlaxoSmithKline (GSK)社�?�核酸系逆転写酵素阻害剤（NRTI）�?�多剤混�?�薬「エプジコム（Epzicom）�?�?�有効性�?�副作用�?�関�?�る新�?��?�データやプロテアーゼ阻害剤�?�利用 Dream News　（プレスリリース）,

�?�?�즈 치료제 시장 경�?열기 후�?�  -  Oct 3, 2008
...�?�부 연구�?서 GSK�?� �?��?�?� '�?�프지컴(Epzicom)'�?� 특정 환�?�?게 효과가 �?고 심근경색 위험 �?가�?� 관련�?� 있어 올해 �?� 많�?� 문제�? �?면했다. 헬스코리아뉴스,

HIV치료제 시장, 성장 중 경�?격화  -  Sep 25, 2008
...게다가 주요제품�?� '엡지컴'(Epzicom, abacavir/ lamivudine)�?� 최근 심근경색 위험과 관련�?� 것으로 드러나면서 전�?�가 어�?워졌다. �?한, 단백분해효소 저해제(PI) 디지틀보사,

India's Aurobindo Pharma gets tentative US FDA approval for ...  -  Sep 8, 2008
...s Epzicom. At 10.54 am, Aurobindo Pharma was trading 1.06 percent higher at 319.40 rupees on the Bombay Stock Exchange, while the benchmark Sensex was 3.91 Forbes,

FDA Announces HIV/AIDS Update  -  Sep 4, 2008
This tentative approval is a generic version of Epzicom Tablets, 600 mg/300 mg, a product of SmithKline Beecham Corporation. Epzicom is subject to existing PharmaLive.com (press release),

Closing Bell  -  Sep 8, 2008
Abacavir sulfate/ lamivudine tablets are the generic equivalent of Epzicom tablets 600mg/ 300mg of SmithKline Beecham Corporation and falls under the Economic Times,

Market Report -- Short Stories (GILD)  -  Sep 2, 2008
Last July, prescriptions for GSK's Combivir and Epzicom were down, but despite the July 4th holiday, Gilead's Ttruvada and Atripla were flat and up slightly MSN Money

Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of ...  -  07 Aug 2008
Abacavir is a key component in Ziagen(R), Trizivir(R) and Epzicom(R). The most significant treatment-limiting event known to occur with abacavir is a MarketWatch

FDA urges genetic test before giving AIDS drug  -  07 Aug 2008
Abacavir is also a component of the combination pills Trizivir and Epzicom. A small percentage of patients - those with a particular variation in an immune Westside Gazette

GlaxoSmithKline Says Studies Show No Increased Risk Of Heart ...  -  07 Aug 2008
...may be associated with cardiac risk, hs-CRP and IL-6, were evaluated from the HEAT trial, a large, randomized, controlled study of Epzicom and Truvada. RTT News,

FDA Approves Expanded Use of Caspofungin Acetate for Paediatric ...  -  07 Aug 2008
NEW YORK -- August 6, 2008 -- The US Food and Drug Administration (FDA) has approved an expanded label for caspofungin acetate (CANCIDAS), as echinocandin DG News

Health Highlights: Aug. 6, 2008  -  07 Aug 2008
The HIV drug abacavir doesn't increase the risk of heart attack, according to an analysis of data from more than 14600 patients in 54 clinical trials. Atlanta Journal Constitution,

UPDATE 1-US urges genetic test before using Glaxo AIDS drug  -  Jul 24, 2008
The drug also is a component of Glaxo's Trizivir, Epzicom and Kivexa AIDS drugs, which had more than $1 billion in combined 2007 sales. Reuters

FDA Urges Genetic Test Before Giving AIDS Drug  -  Jul 23, 2008
It is also a component of two combination pills — Trizivir and Epzicom. The recommendation for the test is part of a movement toward so-called personalized New York Times,

Updated box warning for abacavir treatments  -  Jul 25, 2008
The labels for GlaxoSmithKline’s Trizivir (abacavir sulfate/lamivudine/zidovudine) and Epzicom (abacavir sulfate/lamivudine) will also be updated. Prescribing Reference,

HIV Patients Should Get Treatment Sooner, Panel Says (Update1)  -  Aug 3, 2008
Truvada, made by Gilead Sciences Inc. of Foster City, California, and Epzicom, made by London-based GlaxoSmithKline Plc, are combination drugs patients take Bloomberg

Shire Delivers Strong Quarter: Driven by $243m of New Product ...  -  Jul 31, 2008
...(idursulfase) EPIVIR (R) (lamivudine) (trademark of GSK) EPZICOM(R)/KIVEXA (lamivudine) (trademark of GSK) (EPZICOM) FIRAZYR(R) (icatibant) (trademark MarketWatch

Gilead Sciences And Merck & Co., Inc. Agree To Register And ...  -  Aug 4, 2008
Epivir® or Epivir-HBV® (lamivudine), Epzicom® (abacavir sulfate/lamivudine), or Trizivir® (abacavir sulfate/ lamivudine/zidovudine). Medical News Today (press release),

Gilead Sciences 2nd-qtr profit rises 8.6 pct  -  Jul 17, 2008
Gilead as benefited from the emergence of AIDS trial data earlier this year showing that regimens containing Epzicom, a two-drug combination pill sold by guardian.co.uk,

Genetic Screening Recommended Before Abacavir HIV Therapy  -  Jul 25, 2008
These include abacavir in combination with lamivudine (Epzicom, GlaxoSmithKline) and lamivudine/zidovudine (Trizivir, GlaxoSmithKline). Medscape (subscription)

FDA Announces Important Safety-Related Label Update for Ziagen ...  -  Jul 23, 2008
ZIAGEN contains abacavir (also contained in EPZICOM® and TRIZIVIR®). Patients taking ZIAGEN may have a serious allergic reaction (hypersensitivity reaction) PharmaLive.com (press release),

Gilead Sciences, Inc. Q2 2008 Earnings Call Transcript  -  Jul 31, 2008
Patients previously on Combivir continue to dominate switch patients, comprising approximately 40% of those that switched to Atripla with Epzicom comprising Seeking Alpha,

HIV-Medikament begünstigt Herzinfarkt  -  Jul 11, 2008
Im deutschsprachigen Raum ist Abacavir vor allem unter seinem Handelsnamen Ziagen bekannt, es ist auch in Medikamenten wir Trizivir und Kivexa oder Epzicom GGG.at,

EEUU aconseja test genético antes de usar fármaco contra el sida ...  -  Jul 24, 2008
El fármaco también es uno de los componentes de los medicamentos de Glaxo contra el sida Trizivir, Epzicom y Kivexa, que presentaron ventas por más de 1.000 El Universal (Venezuela),

EEUU aconseja test genético antes de usar fármaco sida de Glaxo  -  Jul 24, 2008
El fármaco también es uno de los componentes de losmedicamentos de Glaxo contra el sida Trizivir, Epzicom yKivexa, que presentaron ventas por más de 1.000 EcoDiario.es,

Gilead shares rise on analyst view for HIV drugs  -  Jun 19, 2008
GlaxoSmithKline (nyse: GSK - news - people )'s Epzicom contains abacavir. "The effects of the abacavir safety and efficacy concerns could be even more Forbes,

For Gilead, Growth Beyond AIDS  -  Jun 29, 2008
Sales growth is likely to continue, not least because recent studies show that HIV drugs containing abacavir, including GlaxoSmithKline's (GSK) Epzicom, Barron's

The Top 60: echo Torre Lazur  -  Jun 30, 2008
GSK's HIV franchise, for which Echo Torre Lazur won the professional assignment in April 2007, includes Lexiva, Epzicom, Combivir and Trizivir. Medical Marketing and Media,

Gilead 1st-Quarter Net Rises 22% on HIV Drug Demand (Update3)  -  Apr 16, 2008
Gilead's best-seller, Truvada, was found more effective at controlling high amounts of the virus than GlaxoSmithKline Plc's Epzicom in a study of 1858 Bloomberg

UPDATE 2-Gilead 1st-quarter profit rises 22 pct  -  Apr 16, 2008
Gilead has benefited from the emergence of AIDS trial data earlier this year showing that regimens containing Epzicom, a two-drug combination pill sold by Reuters

Gilead Sciences Q1 Profit Rises On HIV Drug Sales - Update [GILD]  -  Apr 16, 2008
Epzicom contains abacavir, which is feared to increase the risk of heart attack. Sales of Hepsera, for Chronic Hepatitis B, rose 16% to $83.0 million. RTT News,

A Punch to Gilead's Competition  -  Apr 3, 2008
Sales of Ziagen by itself and in combination with other Glaxo HIV drugs in its Trizivir and Epzicom combination therapies were $1.33 billion last year. Motley Fool

AIDS drug boosts heart attack risk  -  Apr 2, 2008
A federal panel this year recommended that abacavir, combined with the anti-viral 3TC and sold as Epzicom, be considered a preferred choice for patients United Press International

Gilead Sciences, Inc. Q1 2008 Earnings Call Transcript  -  Apr 16, 2008
The second, ACTG 5202 is a US-based study, conducted by the AIDS Clinical Trial Group and sponsored by NIAID, comparing in part Truvada and Epzicom Seeking Alpha,

Kenya: GSK Allays Fears Over Aids Drug and Heart Attack  -  Apr 7, 2008
The drug is also a component of the firm's Trizivir, Epzicom and Kivexa Aids drugs, which had more than $1 billion (Sh62 billion) in combined 2007 sales. AllAfrica.com,

AIDS drug tied to heart attack risk, study says  -  Apr 2, 2008
In January, a federal panel that sets treatment guidelines recommended that the drug, combined with the antiviral 3TC and sold as Epzicom, be considered a San Francisco Chronicle,

Glaxo's HIV Drug May Be Linked To Heart Attack Risk -Study  -  Apr 1, 2008
Ziagen's active ingredient, abacavir, is also used in GlaxoSmithKline's combination HIV drugs Trizivir and Epzicom. Another less commonly used HIV treatment CNNMoney.com

Gilead Sciences hit new high on IMS data  -  Mar 31, 2008
..."As we noted with Truvada, we expect patients are switching from (GlaxoSmithKline PLC's) Epzicom and more broadly Abacavir-containing regimens to BusinessWeek

HIV drugs being checked for safety  -  Mar 28, 2008
Abacavir, the active ingredient in Ziagen, is also in three other HIV drugs that GSK markets: Trizivir, Epzicom and Kivexa. Together, the four drugs News & Observer,

Shire plc: IFRS Results for the Year Ending December 31, 2007  -  Mar 25, 2008
In 2007 generic drug companies filed Abbreviated New Drug Applications ("ANDA") seeking approval for Epivir, Combivir, Zeffix and Epzicom in the US. MSN Money

US reviewing safety of Glaxo, Bristol AIDS drugs  -  Mar 27, 2008
The drug also is a component of Glaxo's Trizivir, Epzicom and Kivexa AIDS drugs, which had more than $1 billion in combined 2007 sales. Scientific American

HIV Drugs Reviewed for Heart Attack Risk  -  Mar 29, 2008
Ziagen—known generically as abacavir—is a component of Glaxo’s Trizivir, Epzicom, and Kivexa AIDS drugs. Also, Bristol-Myers spokeswoman Sonia Choi said “we Newsinferno.com,

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com